Summary
The literature on the transmission of human immunodeficiency virus (HIV/HTLV-III/LAV) is reviewed. HIV spreads by vertical transmission and by iatrogenic transmission (transfer of blood or blood-containing products), by infected needles among i.v. drug users and, more rarely, among health care workers, but mainly by sexual contact. In Western countries the virus is mainly spread by passive anal intercourse among homosexuals and seldom by heterosexual intercourse. In African countries, however, the virus is mainly spread by heterosexual intercourse, probably because of other, concurring sexually transmitted diseases. Some preventive measures are discussed.
Zusammenfassung
Die Literatur zur Übertragung des menschlichen Immundefizienz-Virus (HIV/HTLV-III/LAV) wird in einer Übersicht zusammengefaßt. Die Ausbreitung von HIV erfolgt durch vertikale und iatrogene Übertragung (Transfusion von Blut oder Blutprodukten), bei Drogensüchtigen durch infizierte Nadeln; seltener breitet sich HIV auf Pflegepersonal aus; der Hauptausbreitungsweg erfolgt jedoch durch sexuellen Kontakt. In westlichen Ländern wird das Virus vorwiegend unter Homosexuellen durch passiven analen Verkehr verbreitet, seltener durch heterosexuellen Geschlechtsverkehr, während dies der Hauptausbreitungsweg in afrikanischen Ländern ist. Möglicherweise spielen andere, gleichzeitig bestehende Geschlechtskrankheiten dabei eine begünstigende Rolle. Einige Präventivmaßnahmen werden diskutiert.
Similar content being viewed by others
Literature
Robertson, J. R., Bucknall, A. B. V., Welsbey, P. D., Roberts, J. J. K., Inglis, J. M., Peutherer, J. F., Brettl, R. P. Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. Br. Med. J. 292 (1986) 527–529.
Black, J. L., Dolan, M. P., DeFord, H. A., Rubenstein, J. A., Penk, W. E., Robinowitz, R., Skinner, J. R. Sharing of needles among users of intravenous drugs. N. Engl. J. Med. 314 (1986) 446–447.
Cohen, H., Marmor, M., Des Jarlais, D. C.: Behavioral risk factors for HTLV-III/LAV seropositivity among intravenous drug abusers. The International Conference on the Acquired Immunodeficiency Syndrome: Abstracts, American College of Physicians 1985.
Weiss, S. H., Ginzburg, H. M., Goedert, J. J.: Risk for HTLV-III exposure and AIDS among parenteral drug abusers in New Jersey. The International Conference on the Acquired Immunodeficiency Syndrome: Abstracts, American College of Physicians 1985.
Ginzberg, H. M., Weiss, S. H., MacDonald, M. G., Hubbard, R. L. HTLV-III exposure among drug users. Cancer Res. 45 (Suppl.) (1985) 4605–4608.
Andreyev, H. J. M. Selling syringes to drug addicts. Lancet II (1985) 1192–1193.
Des Jarlais, D. C., Friedman, S. R., Hopkins, W. Risk reduction for the acquired immunodeficiency syndrome among i.v. drug users. Ann. Intern. Med. 103 (1985) 755–759.
Ball, S. E., Hows, J. M., Wersley, A. M., Luzatto, L. Seroconversion of human T-cell lymphotropic virus (HTLV-III) in patients with haemophilia: a longitudinal study. Br. Med. J. 290 (1985) 1705.
Moffat, E. H., Bloom, A. L., Mortimer, P. P. HTLV-III antibody status and immunological abnormalities in haemophiliac patients. Lancet I (1985) 935.
Gjerset, G. F., McCracky, G., Counts, R. B., Martin, P. J., Jason, J., Kennedy, S., Evatt, B., Hansen, J. A. Lymphadenopathy-associated virus antibodies and T-cells in hemophiliacs treated with cryoprecipitate or concentrate. Blood 66 (1985) 718–720.
Ludlam, C. A., Steel, C. M., Cheingsong-Popov, G. D., McClelland, D. B. L., Prescott, R. J., Tucker, J., Tedder, R. S., Weiss, R. A., Philp, I. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet II (1985) 233–236.
Melbye, M., Madhok, R., Sarin, P. S., Lowe, G. D., Goedert, J. J., Froebel, K. S., Biggar, R. J., Stenbjerg, S., Forbes, C. D., Gallo, R. C., Ebbesen, P. HTLV-III seropositivity in European haemophiliacs exposed to factor VIII concentrate imported from the USA. Lancet II (1984) 1444–1446.
Jones, P. J., Hamilton, P. J., Bird, G., Fearns, M., Oxley, A., Tedder, R., Cheingsong-Popov, R., Codd, A. AIDS and haemophilia: morbidity and mortality in a well defined population. Br. Med. J. 291 (1985) 695–699.
Felding, P., Nilsson, J. M., Hansson, B. G., Biberfeld, G. Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat treated factor VIII concentrate of American origin. Lancet II (1985) 832–833.
Biberfeld, G., Bottiger, B., Karlson, A., Sandström, E., Morfeldt-Manssin, L., Blomback, M., Nilsson, I., Wiechel, B., Saxinger, L., Gallo, R. C. HTLV-III infection in homosexuals and hemophiliacs in Sweden. Cancer Res. (Suppl.) 45 (1985) 4609–4611.
Carr, R., Veitch, S. E., Edmond, E., Prescot, R. Y., Peutherer, J. F., Steel, C. M., Ludlam, C. A. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS free population. Lancet I (1984) 1431–1434.
Lee, C. A., Bofill, M., Janossy, G., Thomas, H. C., Rizza, C. R., Kernoff, P. B. A. Relationships between blood product exposure and immunological abnormalities in English haemophiliacs. Br. J. Haemotol. 60 (1985) 161.
Ragni, M. V., Tegtmeyer, G. E., Levy, J. A., Kaminsky, L. S., Lewis, J. H., Spero, J. A., Bontempo, F. A., Handwerk-Leber, C., Bayer, W. L., Zimmerman, D. H., Britz, J. A. AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate or fresh frozen plasma: prevalence, seroconversion rate and clinical correlations. Blood 67 (1986) 592–595.
Goedert, J. J., Sarngadharan, M. G., Eyster, M. E., Weiss, S. H., Bodmer, A. J., Gallo, R. C., Blattner, W. A. Antibodies reactive with human T-cell leukemia viruses in the serum of haemophiliacs receiving factor VIII concentrate. Blood 65 (1985) 492.
Rouzioux, C., Chamaret, S., Montagnier, L., Carnelli, V., Rolland, G., Mannucci, P. M. Absence of antibodies to AIDS virus in haemophiliacs treated with heat treated factor VIII concentrates. Lancet II (1985) 271–272.
Mosseler, J., Schimpf, K., Auerswald, G., Bayer, H., Sneider, J., Hunsmann, G. Inability of pasteurised factor VIII preparations to induce antibodies to HTLV-III after long term treatment. Lancet I (1985) 1111.
White, G. C., Matthews, T. J., Weinhold, K. Y., Haynes, B. F., LeRoy Cromartie, H., McMillan, C. W., Bolognesi, D. P. HTLV-III seroconversion associated with heat-treated factor VIII concentrate. Lancet I (1986) 611–612.
Van den Berg, W., Ten Cate, J. W., Breederveld, C., Goudsmit, J. Seroconversion to HTLV-III in haemophiliac given heat-treated factor VIII concentrate. Lancet I (1986) 803–804.
Centers for Disease Control Update: Acquired immunodeficiency syndrome — United States. J. Am. Med. Assoc. 255 (1986) 593–598.
Peterman, Th. A., Jaffe, H. W., Feorino, P. M., Getchell, J. P., Warfield, D. T., Haverkos, H. W., Stoneburner, R. L., Curran, J. W. Transfusion associated acquired immunodeficiency syndrome in the United States. J. Am. Med. Assoc. 254 (1985) 2913–2917.
Bennett, J. A. AIDS: epidemiology update. Am. J. Nurs. Sept. 85 (1985) 968–972.
Esteban, J. L., Tai, C. C., Kay, J. W. D., Shih, J. W. K., Bodmer, A. J., Alter, H. J. Importance of Western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet II (1985) 1083–1086.
Scheiermann, N., Gesemann, M., Riffelmann, H. D. Nachweis von anti-HTLV-III Antikörpern in Gamma-Globulinpräparaten zur intramuskulären Injektion. Dtsch. Med. Wochenschr. 110 (1985) 1912–1913.
Centers for Disease Control Isolation of HTLV-III/LAV from samples of serum protein given to cancer patients — Bahamas. J. Am. Med. Assoc. 254 (1985) 1139.
Barré-Sinoussi, F., Nugèyre, M. T., Girard, M., Tron, F., Chermann, J. C. Laboratory and serological studies argue against possible transmission in health workers by hepatitis B vaccination. J. Am. Med. Assoc. 254 (1985) 1064–1066.
Dienstag, J. L., Werner, B. G., McLane, M. T., Snydman, D. R., Grady, G. F., Craven, D. E., Crumpacker, C. S., Polk, B. F., Platt, R., Allan, J., Essex, M. Absence of antibodies to HTLV-III in health care workers after hepatitis B vaccination. J. Am. Med. Assoc. 254 (1985) 1064–1066.
L'Age-Stehr, J., Schwarz, A., Offermann, G., Langmaack, H., Bennhold, I., Niedrig, M., Koch, M. A. HTLV-III infection in kidney transplant recipients. Lancet II (1985) 1361–1362.
Prompt, C. A., Reis, M., Grillo, F. M., Kopstein, J., Kraemer, E., Manfro, R. C., Maia, M. H., Comiran, J. B. Transmission of AIDS virus at renal transplantation. Lancet II (1985) 672.
Neumayer, H. H., Wagner, K., Kresse, S. HTLV-III antibodies in patients with kidney transplants or on haemodialysis. Lancet I (1986) 497.
Fujikawa, L. S., Salahuddin, S. Z., Palestine, A. G., Nussenblatt, R. B., Masur, H., Gallo, R. C. Isolation of human T-cell leukemia/lymphotropic virus type III (HTLV-III) from tears of a patient with the acquired immunodeficiency syndrome (AIDS). Lancet II (1985) 528–530.
Salahuddin, S. Z., Palestine, A. G., Heck, E., Ablashi, D., Luckenbach, M., McCulley, J. P., Nussenblatt, R. B. Isolation of the human T-cell leukemia/lymphotropic virus type III from the cornea. Am. J. Ophthalmol. 101 (1986) 149–152.
Stewart, G. J., Cunningham, A. L., Driscoll, G. J., Tyler, J. P. P., Barr, J. A., Gold, J., Lamont, B. J. Transmission of the human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet II (1985) 581–584.
Stricof, R. L., Morse, D. L. HTLV-III/LAV seroconversion following a deep intramuscular needlestick injury. N. Engl. J. Med. 314 (1986) 1115.
Anonymous Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet II (1984) 1376–1377.
Weiss, S. H., Saxinger, W. C., Rechtman, D. HTLV-III infection among health care workers. J. Am. Med. Assoc. 254 (1985) 2089–2093.
Centers for Disease Control Summary: Recommendations for preventing transmission of infection with HTLV-III/LAV in the workplace. J. Am. Med. Assoc. 254 (1985) 3023–3026.
Centers for Disease Control Apparent transmission of human T-lymphotropic virus type III/lymphadenopathy associated virus from a child to a mother providing health care. MMWR 35 (1986) 76–79.
Werner, B. G., Grady, G. F. Accidental hepatitis B-surface-antigen-positive inoculations. Use of e-antigen to estimate infections. Ann. Intern. Med. 97 (1982) 367–369.
Friedland, G. H., Saltzman, B. R., Rogers, M. F., Kahl, P. A., Lesser, M. L., Mayers, M. M., Klein, R. S. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS and AIDS-related complex with oral candidiasis. N. Engl. J. Med. 314 (1986) 344–349.
Lawrence, D. N., Jason, J. M., Bouhasin, J. D., McDougal, J. S., Kuntse, A. P., Evatt, B. L., Joist, J. H. HTLV-III/LAV antibody status of spouses and household contacts assisting in home infusion of hemophilia patients. Blood 66 (1985) 703–705.
Kaplan, J. E., Oleske, J. M., Getchell, J. P., Kalyanaraman, V. S., Minnefor, A. B., Zarbaia-Ablan, M., Joski, V., Denny, Th., Cabradilla, C. D., Rogers, M. F., Sarnadharan, M. G., Sliski, A., Gallo, R. C., Francis, D. P. Evidence against transmission of human T lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome. Pediatr. Infec. Dis. 4 (1985) 468–471.
Goedert, J. J., Biggar, R. A., Winn, D. H., Mann, D. L., Byar, D. P., Strong, D. M., Digioia, R. A., Grossman, R. J., Sanchez, W. C., Kase, R. G., Greene, M. H., Hoover, R. N., Blattner, W. A. Decreased helper T lymphocytes in homosexual men. II. Sexual practices. Am. J. Epidemiol. 121 (1985) 637–644.
Mayer, K. H., Ayotte, D., Groopman, J. E., Stoddard, A. M., Sarngadharan, M., Gallo, R. C. Association of human T lymphotropic virus antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Am. J. Med. 80 (1986) 357–363.
Van Griensven, G. J. P., Tielman, R. A. P., Goudsmit, J., Van der Noordaa, J., De Wolf, F., Coutinho, R. A. Risicofaktoren en prevalentie van LAV/HTLV III antistoffen bij homoseksuele mannen in Nederland. T. Soc. Gezondheidsz. 64 (1986) 100–107.
Lyman, D., Winkelstein, W., Ascher, M., Levy, J. A. Minimal risk of transmission of AIDS-associated retrovirus infection by oral-genital contact. J. Med. Assoc. 255 (1986) 1703.
Schechter, M. T., Boyko, W. J., Douglas, W. J., Maynard, M., Willoughy, B., McLeod, A., Craib, K. J. Can HTLV-III be transmitted orally? Lancet I (1986) 379.
Centers for Disease Control Heterosexual transmission of human T lymphotropic virus type III/lymphadenopathy-associated virus. MMWR 34 (1985) 17.
Acheson, E. D. AIDS: a challenge for the public health. Lancet I (1986) 662–666.
Redfield, R. R., Markham, P. D. Saluhuddin, S. Z., Wright, C., Samgadharan, M. G., Gallo R. C. Heterosexually acquired HTLV/LAV disease (AIDS-related complex and AIDS): Epidemiologic evidence for female to male transmission. J. Am. Med. Assoc. 254 (1985) 2094–2096.
Redfield, R. R., Wright, D. C., Markham, P. D., Salahuddin, S. Z., Sarngadharan, S. Z., Gallo, R. C. Female-to-male transmission of HTLV-III. J. Am. Med. Assoc. 255 (1986) 1705–1706.
Calabrese, L. H., Gopalakrishan, K. V. Transmission of HTLV-III infection from man to woman to man. N. Engl. J. Med. 314 (1986) 987.
Monteiro, E., Wilson, J., Konghorn, G. R. The natural history of HTLV-III infection. Br. Med. J. 292 (1986) 341–342.
Piot, P., Quinn, T. C., Taelman, H., Feinsod, F. M., Minlangu, K. B., Wohin, O., Ndangi, K., Stevens, W., Kalambayi, K., Mitchell, S., Bridts, C., McCormick, J. B. AIDS in an heterosexual population in Zaïre. Lancet II (1984) 65–69.
Biggar, R. J., Gigase, P. L., Melbye, M., Kestens, L., Sarin, P. S., Bodmer, A. J., Demedts, P., Stevens, W. J., Palulu, L., Delacollette, C., Blattner, W. A. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet II (1985) 520–523.
Biggar, R. J. The AIDS problem in Africa. Lancet I (1986) 79–82.
Saxinger, C., Levine, P. H., Lange-Wantrin, G., Gallo, R. C. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Cancer Res. (Suppl.) 45 (1985) 4624–4626.
Rodriquez, L., Dewhurst, S., Sinangil, F., Merino, F., Godoy, G., Volsky, D. J. Antibodies to HTLV-III/LAV among aboriginal Amazonian Indians in Venezuela. Lancet II (1985) 1098.
Volsky, D. J., Wu, Y. T., Stevenson, M., Dewhurst, S., Sinangil, F. Antibodies to HTLV-III/LAV in Venezuelan patients with acute malarial infections. N. Engl. J. Med. 314 (1986) 647–648.
Barin, F., M'Boup, S., Denis, F., Kanki, P., Allan, J. S., Lee, T. H., Essex, M. Serological evidence for virus related to Simian T-lymphotropic retrovirus III in residents of West Africa. Lancet II (1985) 1387–1389.
Des Jarlais, D. C., Feldman, D., Wish, E., Friedman, S. R., Brady, E., Cuadrado, M.: Heterosexual HTLV-III/LAV transmission and „safer“ sexual practices in Rwanda and New York City. “AIDS in Africa”, Congress, 22–23 November 1985, Bruxelles, Belgium.
Clumeck, N., Van de Perre, P., Carael, M., Rowroy, D., Nzaramba, D. Heterosexual promiscuity among African patients with AIDS. N. Engl. J. Med. 313 (1985) 182.
Van de Perre, P., Kanyamupira, J. B., Carael, M., Bogaerts, J., Akingeneye, E., De Mol, P., Sibomana, J., Le Pollain, B., Nzabimana, E., Kayhigi, J., Clumeck, N.: HTLV-III/LAV infection in Central Africa. “AIDS in Africa”, Congress, 22–23 November 1985, Bruxelles, Belgium.
Pape, J. W., Liautaud, B., Thomas, F., Mathurin, J., Amand, M. A. St., Boncy, M., Pean, V., Pamphile, M., Laroche, C., Dehorte, J., Johnson, W. D. The acquired immunodeficiency syndrome in Haiti. Ann. Intern. Med. 103 (1985) 674–678.
Kreiss, J. K., Koech, D., Plummer, F. A., Holmes, K. K., Lightfoote, M., Piot, P., Ronald, A. R., Ndinya-Achola, J. O., Lourdes, C. B., D'Costa, C. B., Roberts, P., Ngugi, E. N., Quinn, T. C. AIDS virus infection in Nairobi prostitutes. N. Engl. J. Med. 314 (1986) 414–418.
Carael, M., Van de Perre, P., Akingeneye, E., Kanyamupira, J. B., Butzler, J. P., Clumeck, N.: Sociocultural factors in relation to HTLV-III/LAV transmission in urban areas in Central Africa. “AIDS in Africa”, Congress, 22–23 November 1985, Bruxelles, Belgium.
Serwadda, D., Mugerwa, R. D., Sewankambo, N. K., Lwegaba, A., Carswell, J. W., Kirwa, G. B., Bayley, A. C., Downing, R. G., Tedder, R. S., Clayden, S. A., Weiss, R. A., Dalgleishi, A. G. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet II (1985) 849–832.
Williams, C. K. O. AIDS and cancer in Nigerians. Lancet I (1985) 36–37.
Zuckerman, A. J. AIDS and insects. Br. Med. J. 292 (1986) 1094–1095.
Park, W. P., Scott, G. B. Pediatric AIDS: A disease spectrum causally associated with HTLV-III infection. Cancer Res. 45 (Suppl.) (1985) 4659–4661.
Schäfer, A., Jovaisas, E., Stauber, M., Lowerthal, D., Koch, M. A. Nachweis einer diaplazentaren Übertragung von HTLV-III/LAV vor der 20. Schwangerschaftswoche. Geburtshilfe Frauenheilkd. 46 (1986) 88–89.
Chiodo, F., Ricchi, E., Costigliol, P., Michelacci, L., Bovicelli, L., Dallacasa, P. Vertical transmission of HTLV-III. Lancet I (1986) 739.
Lapointe, M., Michaud, J., Petrovic, D., Chausreau, J. P., Dupuy, J. M. Transplacental transmission of HTLV-III virus. N. Engl. J. Med. 312 (1985) 1325–1326.
Ziegler, J. B., Cooper, D. A., Johnson, R. V., Gold, J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet I (1985) 896.
Salahuddin, S. Z., Markham, P. D., Redfield, R. R., Essex, M., Groopman, J. E., Sarngadharan, M. G., McLane, M. F., Sliski, A., Gallo, R. C. HTLV-III in symptom-free seronegative persons. Lancet II (1984) 1418–1420.
Levy, J. A., Mitra, G., Mozen, M. M. Recovery and inactivation of infectious retroviruses from factor VIII concentrate. Lancet I (1985) 271–272.
Schechter, M. T., Jeffries, E., Constance, P. Changes in sexual behavior and fear of AIDS. Lancet I (1984) 1293.
Jaffe, H. W., Hardy, A. M., Morgan, M. The acquired immunodeficiency syndrome in gay men. Ann. Intern. Med. 103 (1985) 662–664.
Conant, M., Hardy, D., Sernatinger, J., Spicer, D., Levy, J. A. Condoms prevent transmission of AIDS-associated retrovirus. J. Am. Med. Assoc. 255 (1986) 1706.
Katznelson, S., Drewe, W. L., Mintz, L. Efficacy of the condom as a barrier to the transmission of cytomegalovirus. J. Infect. Dis. 150 (1984) 155–157.
Kubanek, B., Koerner, K. Hüfigkeit von HTLV-III-Antikörpern bei Blutspendern des Deutschen Roten Kreuzes. Dtsch. Med. Wochenschr. 111 (1986) 516–517.
Collier, A. C., Barnes, R. C., Handsfield, H. H. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle. Am. J. Public Health 76 (1986) 564–565.
Jesson, W. J., Thorp, R. W., Mortimer, P. P., Oates, J. K. Prevalence of anti-HTLV-III in UK risk groups 1984/85. Lancet I (1986) 155.
Gerstoft, J., Lindhardt, B. O., Petersen, C. S., Kroon, S., Ullman, S., Moller, S., Nielsen, J. O., Dickmeiss, E. Antibodies to human T-cell lymphotropic virus type III on promiscuous healthy homosexual men. Relation to immunological and clinical findings. Eur. J. Clin. Invest. 15 (1985) 290–295.
Sirianni, M. C., Rossi, P., Moroni, M., Romagnani, S., Lazzarin, A., Carbonari, M., Scarpati, B., Mariani, M., Manconi, P. E., Del Giacco, G. S., Aiuti, F. Demonstration of antibodies to human T-lymphotropic retrovirus type III in lymphadenopathy syndrome patients and in individuals at risk for acquired immune deficiency syndrome (AIDS) in Italy. Am. J. Epidemiol. 123 (1986) 308–315.
Centers for Disease Control Prevalence of HTLV-III/LAV antibody in heterosexual populations — United States. J. Am. Med. Assoc. 255 (1986) 185.
Lindhardt, B. O., Gerstoft, J., Ulrich, K., Bentzen, K., Scheibel, E., Nielsen, J. D., Dickmeiss, E. Antibodies against HTLV-III in Danish haemophiliacs: relation to source of factor VIII used in treatment and immunological parameters. Scand. J. Haematol. 35 (1985) 379–385.
Zoulek, G., Gürtler, L., Eberle, J., Lorbeer, B., Deinhardt, F. Zunahme der Prävalenz von Antikörpern gegen LAV/HTLV-III bei Drogenabhängigen in der Bundesrepublik Deutschland. Dtsch. Med. Wochenschr. 111 (1986) 567–570.
Redfield, R. R., Markham, P. D., Salahuddin, S. Z., Sarngadharan, M. G., Bodner, A. J., Folks, T. M., Ballou, W. R., Wright, C., Gallo, R. C. Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS. J. Am. Med. Assoc. 253 (1985) 1571–1573.
Kreiss, J. K., Kitchen, L. W., Prince, H. E., Kasper, C. K., Essex, M. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Ann. Intern. Med. 102 (1985) 623–626.
Jones, P., Hamilton, P. J., Bird, G., Fearns, M., Oxley, A., Tedder, R., Cheingsong-Popov, R., Codd, A. AIDS and haemophilia: morbidity and mortality in a well-defined population. Br. Med. J. 291 (1985) 695–699.
Luzi, G., Ensoli, B., Turbesi, G., Scarpati, B., Aiuti, F. Transmission of HTLV-III infection by heterosexual contact. Lancet II (1985) 1018.
Jason, J. M., McDougal, J. S., Dixon, G., Lawrence, D. N., Kennedy, M. S., Hilgartner, M., Aledert, L., Evat, B. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. J. Am. Med. Assoc. 255 (1986) 212–215.
Barton, S. E., Underhilt, G. S., Gilchrist, C., Jeffries, D. J., Harris, J. R. W. HTLV-III antibody in prostitutes. Lancet II (1985) 1424.
Brenky-Faudeux, D., Fribourg-Blanc, A. HTLV-III antibody in prostitutes. Lancet II (1985) 1424.
Tirelli, U., Vaccher, E., Carbone, A., De Paoli, P., Santini, G. F., Monfardini, S. HTLV-III antibody in prostitutes. Lancet II (1985) 1424.
Coutinho, R. A., Van der Helm, T. Geen aanwijzingen voor LAV/HTLV-III onder prostituees in Amsterdam die geen drugs gebruiken. Ned. Tijdschr. Geneeskd. 130 (1986) 508.
Papaevangelou, G., Roumeliotou-Karayannis, A., Kallinkos, G., Papoutsakis, G. LAV/HTLV-III infection in female prostitutes. Lancet II (1985) 1018.
Buchanan, D. J., Downing, R. G., Tedder, R. S. HTLV-III antibody in Zambian copperbelt. Lancet I (1986) 155.
Bayley, A. C., Downing, R. G., Cheingsong-Popov, R., Tedder, R. S., Daglfish, A. G., Weiss, R. A. HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet II (1985) 359–361.
Okpara, R. A., Williams, E., Schnedier, J., Wendler, I., Hunsman, G. Antibodies to human T-cell leukemia virus types I and III in blood donors from Calabar, Nigeria. Ann. Intern. Med. 104 (1986) 132.
Brun-Vezinet, F.: Seroepidemiological studies of LAV in Central Africa. “AIDS in Africa”, Congress, 22–23 November 1985, Bruxelles, Belgium.
Georges, A., Lesbordes, J. L., Meunier, D. M. Y., Vohito, M. D., Gonzales, J. P., Guetard, D., Chamaret, S., Bensimon, G., Klatzman, D., Montagnier, L. Antibodies to LAV in various population groups of the Central African Republic. Ann. Inst. Pasteur/Virol. 136 E (1986) 323–325.
Van de Perre, P., Clumeck, N., Carael, M., Nzabikimana, E., Robert-Guroff, M., De Mol, P., Fregens, P., Butler, J., Gallo, R. C., Kanyamupira, J. Female prostitutes: a risk group for infection with human T-cell lymphotropic virus III. Lancet II (1985) 524–527.
Donea-Debroise, B., Sondag-Thuli, D.: Distribution of some virus markers among Rwandese blood donors. “AIDS in Africa”, Congress, 22–23 November 1985, Bruxelles, Belgium.
De-The, G., Gessain, A., Gazzolo, L., Robert-Guroff, M., Najberg, G., Calender, A., Peti, M., Brubaker, G., Bensliman, A., Fabry, F., Robin, Y., Fortune, R. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries. Cancer Res. (Suppl.) 45 (1985) 4633–4636.
Sher, R.: Sero epidemiological studies of HTLV-III/LAV infections in Southern African countries. “AIDS in Africa”, Congress, 22–23 November 1985, Bruxelles, Belgium.
Zagury, D., Lurhuma, K., Gallo, R. C.: HTLV-III/LAV infection in Central Africa. “AIDS in Africa”, Congress, 22–23 November 1985, Bruxelles, Belgium.
Clumeck, N. Robert-Guroff, M., Van de Perre, P., Jenning, A., Sibomana, J., Dernol, P., Cran, S., Gallo, R. C. Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans. J. Am. Med. Assoc. 254 (1985) 2599–2602.
Carswell, J. W., Sewankambo, N., Lloyd, G., Downing, R. G. How long has the AIDS virus been in Uganda? Lancet II (1986) 1217.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Graaf, M., Diepersloot, R.J.A. Transmission of human immunodeficiency virus (HIV/HTLV-III/LAV): A review. Infection 14, 203–211 (1986). https://doi.org/10.1007/BF01644263
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01644263